We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$137M
AUM Growth
-$38.5M
Cap. Flow
-$75.9M
Cap. Flow %
-55.22%
Top 10 Hldgs %
99.81%
Holding
11
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$64M
2
KALA icon
KALA BIO
KALA
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 28.58%
2 Communication Services 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$293M
$22.3M 16.22%
1,139,783
– –
CDLX icon
2
Cardlytics
CDLX
$22.1M
$12.6M 9.14%
20,000
-130,807
-87% -$64M
RNAC icon
3
Cartesian Therapeutics
RNAC
$227M
$6.65M 4.84%
92,449
– –
XFOR icon
4
X4 Pharmaceuticals
XFOR
$377M
$3.33M 2.42%
10,383
– –
STIM icon
5
Neuronetics
STIM
$137M
$3.29M 2.39%
732,583
– –
KALA icon
6
KALA BIO
KALA
$13.6M
$2.09M 1.52%
226
-253
-53% -$2.44M
ATYR
7
aTyr Pharma
ATYR
$47.1M
$544K 0.4%
130,571
– –
GNCA
8
DELISTED
Genocea Biosciences, Inc.
GNCA
$509K 0.37%
246,078
– –
PULM icon
9
Pulmatrix
PULM
$6.21M
$309K 0.22%
17,972
– –
DARE icon
10
Dare Bioscience
DARE
$18.6M
$268K 0.19%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q4 2019 Portfolio in Review

As of Q4 2019, Polaris Venture Management Co V held 11 positions worth $137M, down 22% from $176M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $75.9M in Q4 2019, reducing 3 holdings. Its largest reduction was Cardlytics, cutting an estimated $64M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 22% a quarter earlier, followed by Communication Services.

  • Polaris Venture Management Co V's biggest Q4 2019 reduction was Cardlytics, cutting an estimated $64M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $137M portfolio in Q4 2019.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q4 2019.
  • Polaris Venture Management Co V's portfolio value fell 22% quarter-over-quarter to $137M.

Based on Polaris Venture Management Co V's 13F filing for Q4 2019, filed 12 Feb 2020.